dapivirine has been researched along with AIDS Seroconversion in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 6 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Baeten, JM; Chandran, U; Goetz, BJ; Gordon, KC; Halvas, EK; Hardesty, R; Heaps, AL; Husnik, MJ; Mellors, JW; Palanee-Phillips, T; Parikh, UM; Penrose, KJ; Schwarzmann, W; Sethi, R; Szydlo, DW | 1 |
| Baeten, JM; Barnabas, RV; Brown, ER; Harkoo, I; Hendrix, CW; Hillier, SL; Jeenarain, N; Mirembe, BG; Palanee-Phillips, T; Peebles, K; Reddy, K; van der Straten, A | 1 |
| Craig, C; Mellors, J; Nuttall, J; Parikh, U; Steytler, J; Van Baelen, B; van der Ryst, E; van Niekerk, N; Wallis, C | 2 |
| Baeten, JM; Chandran, U; Goetz, BJ; Heaps, AL; Mellors, JW; Mgodi, NM; Palanee-Phillips, T; Parikh, UM; Penrose, KJ; Sethi, R; Szydlo, D | 1 |
| Baeten, JM; Bekker, LG; Brown, ER; Bunge, K; Chinula, L; Chirenje, Z; Jeenarain, N; Kelly, C; Kiweewa, FM; Makanani, B; Marrazzo, J; Mgodi, N; Naidoo, L; Nair, G; Palanee-Phillips, T; Piper, J; Reddy, K; Siva, S; Soto-Torres, L | 1 |
| Akello, C; Baeten, JM; Balkus, JE; Dadabhai, S; Heaps, AL; Livant, E; Mayo, AJ; Mellors, JW; Mhlanga, F; O'Rourke, C; Parikh, UM; Ramjee, G; Riddler, SA | 1 |
| Bekker, LG; Borremans, M; Carstens, H; Devlin, B; Gama, C; Gill, K; Isaacs, M; Kamali, A; Kapiga, S; Kotze, P; Kusemererwa, S; Louw, C; Mabude, Z; Malherbe, M; Mans, W; Miti, N; Nel, A; Ntshele, S; Nuttall, J; Parys, W; Resseler, S; Rosenberg, Z; Russell, M; Smit, M; Solai, L; Spence, P; Steytler, J; Tempelman, H; Van Baelen, B; van Niekerk, N; Van Roey, J; Vangeneugden, T; Windle, K | 1 |
| purslow, C | 1 |
5 trial(s) available for dapivirine and AIDS Seroconversion
| Article | Year |
|---|---|
HIV-1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial.
Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Mutation; Pyrimidines; Reverse Transcriptase Inhibitors | 2021 |
Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction.
Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA | 2023 |
Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.
Topics: Adult; Anti-HIV Agents; Contraceptive Devices, Female; Double-Blind Method; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Pyrimidines; Vagina; Young Adult | 2020 |
Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring.
Topics: Adult; Africa; Anti-HIV Agents; Contraceptive Devices, Female; Disease Progression; Female; HIV; HIV Infections; HIV Seropositivity; Humans; Pyrimidines; Reverse Transcriptase Inhibitors; Vagina; Young Adult | 2019 |
Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.
Topics: Adolescent; Adult; Double-Blind Method; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Incidence; Middle Aged; Pregnancy; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; South Africa; Uganda; Vagina; Young Adult | 2016 |
4 other study(ies) available for dapivirine and AIDS Seroconversion
| Article | Year |
|---|---|
Brief Report: Dapivirine Ring HIV-1 Prevention Effectiveness for Women Engaged in Vaginal and Anal Intercourse: Insights From Mathematical Modeling.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Contraceptive Devices, Female; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Sexual Behavior | 2023 |
Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials-The Ring Study and DREAM.
Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV Seropositivity; Humans; Reverse Transcriptase Inhibitors; RNA; Viral Load | 2023 |
Brief Report: HIV Drug Resistance Assessment Among Women Who Seroconverted During the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial.
Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV Seropositivity; Humans; Retrospective Studies; Reverse Transcriptase Inhibitors | 2024 |
Researchers announce launch of latest HIV microbicide trial.
Topics: Adolescent; Adult; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Female; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; Humans; Middle Aged; Pyrimidines; Rwanda; South Africa; Young Adult | 2012 |